«Which stent for which coarctation based on mechanical properties?» Modelisation

Similar documents
L essentiel de 2013 Exercice Readaptation et Sport (GERS) Dr Marie Christine Iliou

Paradoxical low flow-low gradient severe aortic stenosis: where are we?

Mitral valve apparatus in Hypertrophic Cardiomyopathy: a specific assessment?

Cardiac Rehabilitation and Electromyostimulation

Echocardiography of the young athlete: Where are the limits? 24 èmes Journées Européennes de la Société Française de cardiologie janvier 2014

P. Messner Pellenc, C. Robert

Hypertrophic Cardiomyopathy or «Athlete s Heart»

What is controversial in diagnostic imaging?

Insuffisance mitrale

MYOCARDITIS AND BIOMARKERS. Dr C. Guenancia Service de Cardiologie CHU Dijon

Continuous and noninvasive arterial blood pressure monitoring

Return to Work (RTW) after Acute Coronary Syndrom (ACS) SFC

Left Ventricular Assist Device and Exercise

Cancer Associated Thrombosis Approach to VTE recurrence

Session: EBC s position on dedicated devices. Pro

Role of Balloons and Stents in Congenital Heart Disease

Lessons for technique and stent choice

Progress In Transcatheter Aortic Valve Implantation

COMPLEX CASES: LEFT MAIN

ENDOVASCULAR REPAIR OF COMPLEX EXTRA-CRANIAL SUPRA-AORTIC ANEURYSMS

3 Year Clinical Outcome and Cost-Effectiveness of FFR- Guided PCI in Stable Patients with Coronary Artery Disease: FAME 2 Trial

Ultimaster clinical results in left main and bifurcations

Longitudinal stent distortion in clinical practice. How common is the problem and does stent design matter?

CoA Stenting Alexandria Experience

Will Bioresorbable Scaffolds Change How We Think About Left Main PCI?

Branch Pulmonary Artery Stenosis Long-term Outcomes of Endovascular Stenting

7-Year Follow-up From a Randomized Trial of Sirolimus-Eluting vs. Everolimus-Eluting Stents in Patients With Coronary Artery Disease (RESET)

Post PCI functional testing and imaging: case based lessons from FFR React

Directional Atherectomy and Gender Outcomes in DEFINTIVE LE

Jose Mª de la Torre Hernandez, MD, PhD, FESC. Cardiologia Valdecilla Hospital Universitario Marques de Valdecilla Santander. SPAIN

Stent Longitudinal Integrity

Optimal Techniques for Obtaining Large Caliber Arterial Access

IVUS vs FFR Debate: IVUS-Guided PCI

Pitfalls in the evaluation of carotid artery stenosis. Serge Kownator «Centre Cardiologique et Vasculaire» Thionville, Fr

Longitudinal compression of the cobalt-chromium. everolimus-eluting stent during Percutaneous Coronary

Nicolas W Shammas, MD, MS

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

COMMENT DEFINIR UN PLURITRONCULAIRE. Didier Carrié CHU Toulouse Rangueil

Resolute Integrity. Independent Conformability Assessment

DISRUPT CAD. Todd J. Brinton, MD Clinical Associate Professor of Medicine Adjunct Professor of Bioengineering Stanford University

Balloon Expandable Covered Stents. Suddenly a Crowded Space

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

LM stenting - Cypher

Optical Coherence Tomography

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Patterns of Restenosis: A Core Lab-driven Assessment of SFA Restenosis and a Potential Shift to Unify Various Trials Lawrence A. Garcia, MD St.

Combine the best of both worlds

Continuing Cardiology Education

XIENCE Sierra INTRODUCING

Selection and Use of Basic Equipment : Guiding Catheters, Wires and Balloons

Coroflex ISAR. Sirolimus Eluting Polymer-Free Coronary Stent System. Vascular Systems

Measurement of Mechanical Properties of Coronary Stents according to the European Standard pren

Longitudinal distortion of coronary stent in the Left Main Stem: A cautionary tale

The latest generation DEB

When Outcomes Matter, Design Matters

Algorithm and Tools for the Uncrossable CTO

Venous stent experience in Arnsberg Michael K. W. Lichtenberg MD, FESC

Mechanical Properties of the GORE TIGRIS Vascular Stent

Vascular V12. Covered Stent. The New Standard of Care

Le# main treatment with Stentys stent. Carlo Briguori, MD, PhD Clinica Mediterranea Naples, Italy

Vessel Preparation: What does it mean and what are the current tools? Lawrence Garcia, MD St. Elizabeth s Medical Center Boston, MA, USA

IMAGES. in PAEDIATRIC CARDIOLOGY

Goal: Optimal Stent Deployment

Affiliation/Financial Relationship Grant/ Research Support: Major Stock Shareholder/Equity Interest: Royalty Income: Ownership/Founder: Salary:

TAVI limitations for low risk patients

NC EMERGE TM PTCA Dilatation Catheter

IMAGES. in PAEDIATRIC CARDIOLOGY

Challenges of in-stent Restenosis. The Balloon Approach

Echo Assessment Pre-TAVI

Is a Stent or Scaffold Necessary in The SFA?

The BIO revolution: bioadsorbable stents. Federico Conrotto Cardiologia 2 Città della Salute e della Scienza di Torino

Coarctation of the aorta (CoA) accounts for

CP STENT. Large Diameter, Balloon Expandable Stent

In-stent Restenosis: the Achille's Heel of SFA Stenting

Magmaris: the impact of scaffold design and materials on reducing thrombogenicity

Clinical results of venous stents. Michael K. W. Lichtenberg MD, FESC

POLish Bifurcation Optimal treatment Strategy randomized Study (POLBOSS) - Interim analysis

Bench Insights into Bifurcation Stenting in the DES Era: An Update

Stent Fracture and Longitudinal Compression on CT Angiography between the

Things we use in the catheter lab: Catheters, wires, balloons, stents, devices. Shakeel A Qureshi Evelina Children s Hospital London

Finally, the Control You Need to Deliver Accurate Treatment

Investigation of metallic surface area of coronary stents

Evaluation of Stent Performances using FEA considering a Realistic Balloon Expansion

Bench test : Is it still useful? Do we need standardization?

Issam D. Moussa, MD. Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, FL

2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route

MULTIVESSEL PCI. IN DRUG-ELUTING STENT RESTENOSIS DUE TO STENT FRACTURE, TREATED WITH REPEAT DES IMPLANTATION

Stents selection and optimal implantation: sizes, design, deployment Abbott Vascular. All rights reserved.

TRANSCATHETER MITRAL VALVE IMPLANTATION FOR SEVERE MITRAL REGURGITATION: THE TENDYNE GLOBAL FEASIBILITY TRIAL 1 YEAR OUTCOMES

Consensus so far and what we will be focusiong on this time

ENDOVASCULAR FEMORAL STENTS CAN WE RELY ON LONG-TERM FRIENDSHIP?

Current Status of Abdominal Aortic Stent Grafts. John R. Laird Professor of Medicine Director of the Vascular Center UC Davis Medical Center

A Case of Recoiling of Everolimus - eluting Stent at the Ostium of the Right Coronary Artery by Out - stent Plaque Progression

Management of Bleeding and Hemolysis. Mauricio G. Cohen, MD, FACC, FSCAI Director, Cardiac Catheterization Lab Professor of

Bifurcations Bad Krozingen I

Absorbable Scaffolds the Future of Coronary Interventions?

Bioabsorbable stents: early clinical results. Dr Angela Hoye MB ChB, PhD Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals

Impact of overxpan/on strategies: Insights from bench Tes/ng

Three-Year Clinical Outcomes with Everolimus-Eluting Bioresorbable Scaffolds: Results from the Randomized ABSORB III Trial Stephen G.

Bifurcation stenting with BVS

Transcription:

«Which stent for which coarctation based on mechanical properties?» Modelisation Patrice Guérin, Clément Mercier, Fabienne Jordanna L Institut du Thorax et Inserm U791 CHU Nantes JFCPC 2015

Déclaration de Relations Professionnelles Disclosure Statement of Financial Interest J'ai actuellement, ou j'ai eu au cours des deux dernières années, une affiliation ou des intérêts financiers ou intérêts de tout ordre avec une société commerciale ou je reçois une rémunération ou des redevances ou des octrois de recherche d'une société commerciale : I currently have, or have had over the last two years, an affiliation or financial interests or interests of any order with a company or I receive compensation or fees or research grants with a commercial company : Affiliation/Financial Relationship Grant/Research Support Consulting Fees/Honoraria Major Stock Shareholder/Equity Royalty Income Ownership/Founder Intellectual Property Rights Other Financial Benefit Company Lilly AstraZeneca Actelion Abbott Vascular

The laboratory Bench test : Camera Binocular magnifying glass Microscanner In-vivo studies Rats Rabbits Pigs

3D reconstruction

In vivo analysis

Pigs : In vivo analysis (2)

Scanning electron microscopy (J28)

Aortic coarctation 8

Texture analyzer TA HD PLUS Measuring the force versus displacement Max Force ± 5kg ± 500kg Force Resolution 0.1g 10g Force Accuracy 0.025% 0.025% Texture Technology

Caliper Measuring range Resolution 0-150mm 0.01mm Fischer scientific 10

Analysed stents Modèle Laboratoire Composition Diamètre d'usage Longueur d'usage AndraStent XL ANDRAMED Cobalt-Chronium 14-25 mm 14-25 mm 1 n AndraStent XXL ANDRAMED Cobalt-Chronium 20-32 mm 16-24 mm 1 Valéo BARD Stainless steel 316L 9 mm NC 2 Covered CP stent 16 mm NuMED Platinium/Iridium (90/10) Covered CP stent 28 mm NuMED Platinium/Iridium (90/10) CP stent 55 mm NuMED Platinium/Iridium (90/10) 12-24 mm 10,5-16,1 mm 1 12-24 mm 19,1-26,2 mm 1 12-24 mm NC 1 Palmaz CORDIS Stainless steel 316L 14-25 mm 37,79-30,58 mm IntraStent Mega LD Stent Ev3 Stainless steel 316L 9-12 mm 26 mm 1 1 IntraStent Max LD Stent Ev3 Stainless steel 316L 12 mm 26 mm 2 IntraStent DoubleStrut LD Stent Ev3 Stainless steel 316L 9-12 mm 56 mm 1

Mechanical tests Recoil and foreshortening Averall compression Overall Radial Force Local compression Segmental Radial Force Longitudinal compression

Mechanical tests Recoil and foreshortening Averall compression Overall Radial Force Local compression Segmental Radial Force Longitudinal compression

Recoil et du Foreshortening Recoil : Diametrical reduction after balloon deflation Foreshortening : Longitudinal reduction between the initial and final state of the stent

Initial Recoil 7,00 % After first inflation at 18 mm Minus 1 mm after deflation in case of 18-20 mm vessel 6,00 % 5,19 % 5,00 % 4,03 % 4,00 % 3,36 % 3,58 % 3,68 % 3,00 % 2,48 % 2,73 % 2,00 % 1,82 % 1,85 % 1,00 % 0,00 % Recoil initial

Mean Recoil 6,00 % 5,00 % 4,52 % 5,18 % Mean recoil after 3 deployement. 4,00 % 3,00 % 2,00 % 1,34 % 1,41 % 2,21 % 2,24 % 3,00 % 3,14 % 3,49 % 1,00 % 0,00 % Recoil moyen Mean Recoil < initial Recoil (except for Palmaz stent)

Foreshortening 50,00 % 45,00 % 45,18 % 40,00 % 35,00 % 30,00 % 25,00 % 20,00 % 15,00 % 10,00 % 5,00 % 6,06 % 9,92 % 13,76 % 14,15 % 14,40 % 14,92 % 16,06 % 18,52 % 0,00 % Foreshortening

Foreshortening 50,00 % 45,00 % 40,00 % 35,00 % 30,00 % 25,00 % 10% : Minus 0.5 cm in lenght for a 45-50 mm stent! 15% : Minus 0.75 cm in lenght for a 45-50 mm stent! 45,18 % 20,00 % 15,00 % 10,00 % 5,00 % 6,06 % 9,92 % 13,76 % 14,15 % 14,40 % 14,92 % 16,06 % 18,52 % 0,00 % Foreshortening

Foreshortening 50,00 % 45,00 % 40,00 % 35,00 % 30,00 % 25,00 % Valeo could be open until 18 mm but should it be (nominal diameter 6-10 mm) 45,18 % 20,00 % 15,00 % 10,00 % 5,00 % 6,06 % 9,92 % 13,76 % 14,15 % 14,40 % 14,92 % 16,06 % 18,52 % 0,00 % Foreshortening

Mechanical tests Recoil and foreshortening Averall compression Overall Radial Force Local compression Segmental Radial Force Longitudinal compression

Overall compression between two parallel plates Determination of the radial force to develop a diametrical reduction of 60% Stent structure Folding Axis

Overall compression between two parallel plates 1400,0 g 1200,0 g 1188,8 g 1000,0 g 996,1 g 908,200 g 800,0 g 600,0 g 694,3 g 667,1 g 586,9 g 558,7 g 538,2 g 460,7 g 400,0 g 200,0 g 0,0 g CP Stent 55mm Palmaz IntraStent DoubleStrut IntraStentMAX IntraStent MEGA CCP Stent 28mm AndraStent XXL Valéo AndraStent XL Force appliquée à 60% de réduction diamétrale There is a relationship between required force and stent s lenght

Overall compression between two parallel plates 40,00 35,00 30,00 31,96 30,58 30,16 29,50 28,45 27,61 25,00 25,22 25,12 22,89 20,00 15,00 15,27 10,00 5,00 0,00 Ratio Force/Lenght Low resistance of intrastent DoubleStrut Ratio (g/mm de stent) Ratio Force _ appliquée longueur_ stent

Overall compression between two parallel plates 40,00 35,00 30,00 31,96 30,58 30,16 29,50 28,45 27,61 25,00 25,22 25,12 22,89 20,00 15,00 15,27 10,00 5,00 0,00 Ratio Force/Lenght Low resistance of intrastent DoubleStrut Ratio (g/mm de stent) Ratio Force _ appliquée longueur_ stent

Overall compression between two parallel plates 40,00 35,00 30,00 31,96 30,58 30,16 29,50 28,45 27,61 25,00 25,22 25,12 22,89 20,00 15,00 15,27 10,00 5,00 0,00 Ratio Force/Lenght Low resistance of intrastent DoubleStrut Ratio (g/mm de stent) Ratio Force _ appliquée longueur_ stent

Overall compression between two parallel plates 40,00 35,00 30,00 31,96 30,58 30,16 29,50 28,45 27,61 25,00 25,22 25,12 22,89 20,00 15,00 15,27 10,00 5,00 0,00 Ratio Force/Lenght Low resistance of intrastent DoubleStrut Ratio (g/mm de stent) Ratio Force _ appliquée longueur_ stent

Determination of the radial force developed locally to 60% of diameter reduction. Local compression

Local compression Stents classification according to the cell resistance to the applied stress 600,0 g 528,3 g 500,0 g 446,1 g 445,0 g 400,0 g 300,0 g 338,0 g 337,5 g 319,4 g 317,7 g 279,1 g 200,0 g 219,1 g 201,4 g 100,0 g 0,0 g Force à 60% de réduction diamétrale 29

Longitudinal reduction of 50% of the original length Longitudinal Compression

Longitudinal Compression 3500,0 g 3000,0 g 2500,0 g 2000,0 g 2868,8 g E 2162,8 g 2117,9 g 1478,3 g E : elastic deformation of the stent E 1500,0 g 1304,8 g 1000,0 g 500,0 g 0,0 g 987,4 g E E 208,5 g 167,2 g E E 71,8 g 62,5 g Force enregistrée à 1 Palmaz, CCP Stent 16mm, CCP Stent 28, CP Stent 55mm : destructurations

Take home messages AndraStent XL : Important recoil and foreshorteningimportant but a good radial force : Short stenosis requiring a good radial force. Curves AndraStent XXL : Important recoil but low foreshortening and an excellent radial force : Recommended. Curves Valéo : Small recoil at 18 mm but very high foreshortening and as a consequence an excellent radial force : should we use it at 18 mm? CP ou CCP stent : Important recoil and foreshortening but a good radial force, intermediate recoil and radial force with important foreshortening (15%) «Classical lesion» without significant curve» Palmaz : The worst recoil, important foreshortening (10%), correct radial force «Classical lesion» without significant curve» IntraStent Mega and Max LD Stent : Low recoil, 13% foreshortening, good radial force «Classical lesion requiring a low recoil and good radial force» IntraStent DoubleStrut LD Stent : No recoil but the lower radial force :» «coarcation of the young in a curve»

AndraStent XL : Important recoil and important foreshortening but a good radial force : Short stenosis requiring a good radial force, curves.

Valéo : Small recoil at 18 mm but very high foreshortening and as a consequence an excellent radial force : should we use it at 18 mm?

CP ou CCP stent : Important recoil and foreshortening but a good radial force, intermediate recoil and radial force with important foreshortening (15%) «Classical lesion» without significant curve

Study limitations n=2 Ex vivo manipulations Ongoing study BVS Bench Testing Appearances are Sometimes Deceptive

Thank you for your attention

Bibliographie Analyseur de Texture TA.HD Plus www.texturetechnologies.com Organisation internationale de normalisation. Implants cardiovasculaires Dispositifs endovasculaires Partie 2 : endoprothèses vasculaires. Genève: ISO, 2013. 20p. Norme internationale ISO 25539-2 :2013 Barragan P, Rieu R, Garitey V, Roquebert PO, Sainsous J, Silvestri M, Bayet G. Elastic recoil of coronary stent: A comparative analysis. Catheter Cardiovasc Interv. 2000 ; 50(1):112-9. Choi H, Joo SM, Kim HK, Shin JH, Hwang MH, Choi J et al. A comparative reliability and performance study of different stent designs in terms of mechanical properties: foreshortening, recoil, radial force, and flexibility. Artif. Organs 2013;37(4):368-79. Ormiston J, Webber B, White J, Ubod B, Webster M. Point compression and stent longitudinal deformation: a novel clinically-relevant bench tests comparing 6 contemporary stent designs. EuroIntervention 2013. doi: 10.1161/CIRCINTERVENTIONS.113.000621 Leibundgut G, Gick M, Toma A, Valina C, Löffelhardt N, Büttner HJ, Neumann F-J. Longitudinal compression of the platinum-chromium everolimus-eluting stent during coronary implantation: Predisposing mechanical properties, incidence, and predictors in a large patient cohort. Catheter Cardiovasc. Interv. 2013; 81(5):e206 214. Schwartz RS, Huber KC, Murphy JG, Edwards WD, Camrud AR, Vlietstra RE, Holmes DR. Restenosis and the Proportional Neointimal Response to Coronary Artery Injury: Results in a Porcine Model. J Am Coll Cardiol. 1992 ;19(2):267-74 Illustration coeur : www.ikonet.com

PKP (POT, Kissing, final POT) Absrorb Final result very similar to PSP Good result on Main branch Bench B Bench A